Patents Assigned to Hasumi LLC
  • Human Lymphocyte Vaccine Adjuvant
    Publication number: 20100266534
    Abstract: The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
    Type: Application
    Filed: June 28, 2010
    Publication date: October 21, 2010
    Applicants: HASUMI LLC, UNIVERSITY OF BALTIMORE, MARYLAND
    Inventors: Kenichiro Hasumi, Dean LeMar Mann, Kim Graulich Hankey, Kristina Michelle Holt
  • Human lymphocyte medium adjuvant
    Patent number: 7745157
    Abstract: The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
    Type: Grant
    Filed: February 20, 2004
    Date of Patent: June 29, 2010
    Assignees: University of Maryland, Baltimore, Hasumi LLC
    Inventors: Kenichiro Hasumi, Dean LeMar Mann, Kim Graulich Hankey, Kristina Michelle Holt